Ligand validation:2VDN

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VDN_GOL_A_1453	53%	90%	0.181	0.943	0.37	0.25	-	-	0	0	100%	1
2VDN_GOL_B_1462	4%	88%	0.386	0.77	0.35	0.33	-	-	0	0	100%	1
2VC2_GOL_B_1478	62%	89%	0.183	0.976	0.36	0.28	-	-	0	0	100%	1
2VDK_GOL_A_1453	52%	92%	0.173	0.931	0.44	0.08	-	-	0	0	100%	1
2VDP_GOL_A_1453	51%	89%	0.181	0.936	0.44	0.2	-	-	0	0	100%	1
2VDM_GOL_B_1463	43%	93%	0.203	0.927	0.37	0.11	-	-	0	0	100%	1
3ZE2_GOL_F_1215	36%	90%	0.185	0.877	0.39	0.22	-	-	0	0	100%	1
1SSX_GOL_A_249	100%	72%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	41%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.